These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9694528)

  • 1. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1998 Jul; 138(1):67-75. PubMed ID: 9694528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.
    Marona-Lewicka D; Nichols DE
    Eur J Pharmacol; 1994 Jun; 258(1-2):1-13. PubMed ID: 7925587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine pharmacology of three serotonin releasers: 1-(1,3-benzodioxol-5-yl)-2-(methylamino)butane (MBDB), 5-methoxy-6-methyl-2-aminoindan (MMAi) and p-methylthioamphetamine (MTA).
    Li Q; Murakami I; Stall S; Levy AD; Brownfield MS; Nichols DE; Van de Kar LD
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1261-7. PubMed ID: 8968349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of antidepressant agents: a review.
    Dekeyne A; Millan MJ
    Behav Pharmacol; 2003 Sep; 14(5-6):391-407. PubMed ID: 14501253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1998 Mar; 345(1):35-9. PubMed ID: 9593591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-HT-releasing agents on the extracellullar hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action.
    Scorza C; Silveira R; Nichols DE; Reyes-Parada M
    Neuropharmacology; 1999 Jul; 38(7):1055-61. PubMed ID: 10428424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
    Marona-Lewicka D; Rhee GS; Sprague JE; Nichols DE
    Pharmacol Biochem Behav; 1996 Jan; 53(1):99-105. PubMed ID: 8848466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
    Fletcher PJ; Sinyard J; Salsali M; Baker GB
    Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding.
    Sánchez C; Hyttel J
    Cell Mol Neurobiol; 1999 Aug; 19(4):467-89. PubMed ID: 10379421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants, and antagonists at neuropeptide receptors.
    Millan MJ; Dekeyne A
    Int J Neuropsychopharmacol; 2007 Oct; 10(5):579-93. PubMed ID: 17076935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of 5-hydroxytryptamine1B receptors and 5-hydroxytryptamine uptake inhibition in the cocaine-evoked discriminative stimulus effects in rats.
    Filip M; Nowak E; Papla I; Przegaliński E
    J Physiol Pharmacol; 2001 Jun; 52(2):249-63. PubMed ID: 11453104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME; Cryan JF; Sullivan A; Dalvi A; Saucy B; Manning DR; Lucki I
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1220-7. PubMed ID: 12183683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):57-70. PubMed ID: 11344903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats.
    Munzar P; Laufert MD; Kutkat SW; Nováková J; Goldberg SR
    J Pharmacol Exp Ther; 1999 Oct; 291(1):239-50. PubMed ID: 10490910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.
    Winter JC; Eckler JR; Doat MM; Rabin RA
    Pharmacol Biochem Behav; 2002 Dec; 74(1):95-101. PubMed ID: 12376156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of tianeptine.
    Alici T; Kayir H; Aygoren MO; Saglam E; Uzbay IT
    Psychopharmacology (Berl); 2006 Jan; 183(4):446-51. PubMed ID: 16292591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor antidepressants on their cardiac effects. Is there any?
    Pacher P; Ungvari Z; Nanasi PP; Furst S; Kecskemeti V
    Curr Med Chem; 1999 Jun; 6(6):469-80. PubMed ID: 10213794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of serotonin release by 5-HT and NA reuptake blockers after systemic administration.
    Auerbach SB; Lundberg JF; Hjorth S
    Neuropharmacology; 1995 Jan; 34(1):89-96. PubMed ID: 7623967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo.
    Auerbach SB; Hjorth S
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):597-606. PubMed ID: 9053730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.